A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT04173793 · COMPLETED
Trial details
- NCT number
- NCT04173793
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2022-09-26
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.